Is NAGE's Pullback A Second Chance For Investors?

"Aging happy and well, instead of sad and sick, is at least under some personal control. We have considerable control over our weight, our exercise, our education, and our abuse of cigarettes and alcohol…," said George E. Vaillant, a renowned Professor of Psychiatry at Harvard Medical School and the Department of Psychiatry, Brigham and Women's Hospital. In today's world, that personal control is evolving - extending beyond lifestyle choices to include how we support our biology at the cellular level.

The stock we are bringing to your attention today is that of Niagen Bioscience Inc. (NAGE), a company pioneering the future of healthy aging through NAD+ science.

Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe Now
Already subscribed? Sign in

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com